Cargando…
Pre-Treatment with Amifostine Protects against Cyclophosphamide-Induced Disruption of Taste in Mice
Cyclophosphamide (CYP), a commonly prescribed chemotherapy drug, has multiple adverse side effects including alteration of taste. The effects on taste are a cause of concern for patients as changes in taste are often associated with loss of appetite, malnutrition, poor recovery and reduced quality o...
Autores principales: | Mukherjee, Nabanita, Carroll, Brittany L., Spees, Jeffrey L., Delay, Eugene R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634019/ https://www.ncbi.nlm.nih.gov/pubmed/23626702 http://dx.doi.org/10.1371/journal.pone.0061607 |
Ejemplares similares
-
Correction: Pre-Treatment with Amifostine Protects against Cyclophosphamide-Induced Disruption of Taste in Mice
por: Mukherjee, Nabanita, et al.
Publicado: (2013) -
Cyclophosphamide and the taste system: Effects of dose fractionation and amifostine on taste cell renewal
por: Delay, Eugene R., et al.
Publicado: (2019) -
Cellular mechanisms of cyclophosphamide-induced taste loss in mice
por: Mukherjee, Nabanita, et al.
Publicado: (2017) -
The therapeutic potential of amifostine on cyclophosphamide-induced testicular dysfunction in rats: An experimental study
por: Kaya, Coskun, et al.
Publicado: (2019) -
Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
por: Pereira, A.F., et al.
Publicado: (2020)